Xuelin Huang

40PUBLICATIONS
119CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpidemiological modellingMolecular targetsInformation systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|May 27, 2026
Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|Apr 24, 2026
Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.

|Jan 21, 2026
MELODY: Mediation Analysis in Logistic Regression for High-Dimensional Mediators and a Binary Outcome.

Sunyi Chi, Xingyu Li, Peng Wei

|Nov 26, 2025
MELODY: Mediation Analysis in Logistic Regression for High-Dimensional Mediators and a Binary Outcome.

Sunyi Chi, Xingyu Li, Peng Wei

|Aug 05, 2025
Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia.

Nicholas J Short, Hagop Kantarjian, Nitin Jain

|May 23, 2025
A Biomarker Signature-Guided Clinical Trial Design for Precision Medicine.

Yuan Li, Dejian Lai, Ruosha Li

Pageof 7

Frequent Collaborators

7 joint publications

Nicholas J Short

7 joint publications

Naval G Daver

6 joint publications

Marina Y Konopleva

5 joint publications

Tapan M Kadia